Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 non » _ non (Expand Search), a non (Expand Search), i non (Expand Search)
Showing 1,081 - 1,100 results of 101,825 for search '(( 5 non decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.57s Refine Results
  1. 1081
    Anion-Assisted Glycosylation of Galactose: A Computational Study

    Anion-Assisted Glycosylation of Galactose: A Computational Study by Kerli Tali (22769704)

    Published 2025
    Save to List
    Saved in:
  2. 1082
    Compatible pollen triggers a decrease in S-RNase transcript levels by a post-transcriptional mechanism.

    Compatible pollen triggers a decrease in S-RNase transcript levels by a post-transcriptional mechanism. by Bolin Liu (59887)

    Published 2009
    Save to List
    Saved in:
  3. 1083
    Opa1 and Marf depletion leads to fragmented mitochondria and overexpression of Drp1<sup>SD</sup> leads to clustered mitochondria in type II NBs.

    Opa1 and Marf depletion leads to fragmented mitochondria and overexpression of Drp1<sup>SD</sup> leads to clustered mitochondria in type II NBs. by Dnyanesh Dubal (12085942)

    Published 2022
    Save to List
    Saved in:
  4. 1084
    A hypoglycaemic <i>milieu</i> decreases NCS viability in a dose-dependent manner.

    A hypoglycaemic <i>milieu</i> decreases NCS viability in a dose-dependent manner. by Shiva Mansouri (2838086)

    Published 2016
    Save to List
    Saved in:
  5. 1085
    FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells.

    FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells. by Franco A. Rossato (588513)

    Published 2014
    Save to List
    Saved in:
  6. 1086
    FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells.

    FASN inhibitors result in decreased ΔΨm and increased superoxide production in melan-a cells. by Franco A. Rossato (588513)

    Published 2014
    Save to List
    Saved in:
  7. 1087
    <i>SIRT6</i> Minor Allele Genotype Is Associated with >5-Year Decrease in Lifespan in an Aged Cohort

    <i>SIRT6</i> Minor Allele Genotype Is Associated with >5-Year Decrease in Lifespan in an Aged Cohort by Mindi J. TenNapel (679433)

    Published 2014
    Save to List
    Saved in:
  8. 1088
    Resveratrol decreases CYP17A1 and CYP21A2 protein expression.

    Resveratrol decreases CYP17A1 and CYP21A2 protein expression. by Nesa Marti (3851059)

    Published 2017
    “…<p>A. Gene expression profiling by qRT-PCR was performed for CYP17, CYP21 and their cofactor POR in H295R cells grown under normal conditions (GM), starvation conditions (SM), metformin (Met) (1mM) treatment and under resveratrol (RSV) (5<u>μM)</u> treatment. …”
    Save to List
    Saved in:
  9. 1089
    Opioid prescription characteristics among individuals with chronic non-cancer pain or cancer who received an opioid prescription, 2012–2019.

    Opioid prescription characteristics among individuals with chronic non-cancer pain or cancer who received an opioid prescription, 2012–2019. by Sachini Bandara (12324187)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 1090
    Year-to-year within-patient changes in chronic non-cancer pain treatment among patients with opioid prescriptions in the prior year.

    Year-to-year within-patient changes in chronic non-cancer pain treatment among patients with opioid prescriptions in the prior year. by Sachini Bandara (12324187)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 1091
    Expression of the <i>PHO5</i> gene is negatively affected in RNA exosome mutant cells.

    Expression of the <i>PHO5</i> gene is negatively affected in RNA exosome mutant cells. by Ana Novačić (8373573)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 1092
    Proportion of non-sugar sweeteners used in eligible and exempt drinks over time.

    Proportion of non-sugar sweeteners used in eligible and exempt drinks over time. by Madison Luick (17539007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 1093
    CD5-2 decreases established CCM lesions in the hindbrain of <i>Ccm2</i><sup><i>ECKO</i></sup> mice and lesions in the retina of <i>Ccm2</i><sup><i>ECKO</i></sup> mice.

    CD5-2 decreases established CCM lesions in the hindbrain of <i>Ccm2</i><sup><i>ECKO</i></sup> mice and lesions in the retina of <i>Ccm2</i><sup><i>ECKO</i></sup> mice. by Jia Li (160557)

    Published 2020
    Save to List
    Saved in:
  14. 1094
    D-4F and L-5F decrease hepatic mRNA level of genes involved in gluconeogenesis.

    D-4F and L-5F decrease hepatic mRNA level of genes involved in gluconeogenesis. by Kristine C. McGrath (8269155)

    Published 2020
    Save to List
    Saved in:
  15. 1095
    D-4F and L-5F decrease hepatic mRNA levels of genes involved in lipogenesis.

    D-4F and L-5F decrease hepatic mRNA levels of genes involved in lipogenesis. by Kristine C. McGrath (8269155)

    Published 2020
    Save to List
    Saved in:
  16. 1096
    Chronic exposure of human PAC to nicotine decreases carrier-mediated [<sup>3</sup>H] thiamin uptake.

    Chronic exposure of human PAC to nicotine decreases carrier-mediated [<sup>3</sup>H] thiamin uptake. by Padmanabhan Srinivasan (481324)

    Published 2015
    Save to List
    Saved in:
  17. 1097
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1098
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1099
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1100
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: